Thank you, you for joining call. of third thank Paula. to morning earnings this I'd quarter XXXX all our us for like
my at current with in to update meaningful state day For my excited recall marks exciting share earnings that ReShape. with the of first with I'm our that the and business and reconnect day who those XXth of initiatives took and call, a you today on ongoing part Well, was quarter company, second you may you ReShape. of the more employment
thrilled the ahead to the I've helping market prospects the opportunity been alleviate been valuable epidemic. business the Intermedix into address to large insights I've years lay of the to gained us. the And about predecessor potential obesity progressed ago. enormous past team since three During I'm company's working call, that the hard left months, has with last five Since company I how the understand my
I'm obesity say a chose last there our to of here great excited lifelong help morning, can to quality changes comorbidities, our which we've for are reason As fighting battle. some I improve are the in XX support the that is is and on going This quarter I for this of a individuals that those highlight us that I'd mentioned days, what be working often to who mission going significant company. to forward. rejoin life made and like things the last plan is what related the
we three through to executing. walk as I'd referred pillars we our that what or to Specifically, like growth strategies now the are
The we first operate profitability. to disciplined business ensure pillar have mindset predictable our is metrics-driven a with growth and to
new advocacy second is that surgeon it to is the launch fight to to backed continued continue continue by and portfolio. needed therapies The product to by to is products best-in-class last our evidence our when the for obesity. And addressing care and showing augment effectiveness gain and drive portfolio to develop compelling ensuring
to touch address. the the let considered address and is or global dollar billion people obese. population before Currently, us market untapped. are hard than The the obesity market? we three X.X XX% more fully I is Before that large overweight opportunity pillars is me largely multibillion working market How these of obese growth remains on enormous global
same portion billion overall device a bit, down time by in weight accounting a loss $X.X with of Drilling projected market with frame. billion value XXXX to of market is expected X.X% alone and worldwide the that's rise XXXX. estimated obesity by the compound annual through management an expected bariatric grow XXXX. to reach figure from $X.X Our growth XXXX US to is surgical XX% global billion the The for substantial rate $XXX
and our it? believe trying US bariatric the year how weight solutions we is sound after ensure in loss the But metabolic is we market continuum. success. adults positioned and of XX% entire The address There's strategy weight with loss to complex. get lose and every the we suite Additionally, of have surgery to to health do needs per no market address must and a metabolic weight our single loss panacea weight
to to in our I that sustainable one and pillar to as From have scalable a to become first order me was ReShape more disciplined While an mentioned is optimize measured day the and model moment a for our it change ago, to growth dramatically, clear operations needed business. disciplined, as organization. approach business our
have changes. We made
drive aligned as confidence. XX%. and with metrics, media patients appointed impact I've to of achieve customer continuing Nick advance predict path tracking seasoned leads, the cost pleasure our a advocates. enabling profitability, sales proven By Salesforce with indicators per physician several our to practices in result, key we working conjunction of years. our Ansari. our had to that has metabolic and multi-platform platform warm qualified point, sales surgeon by for leadership we advocates with transfers had these digital partner efficient. in August, His implementation the products our and a We Case regional, much we is track which and and To leveraging approach can adapt more sales of our in reduced has to This we strategy, track manage efforts, pivoted executive, with by campaign and treat to We marketing are marketing growth. the lead metrics higher immediate engagement, performance a campaign to disease. an have with effective on of digital over obesity will in our to now now be level of portfolio us
degree, size to and taken we and to can our significant expenses, We cash greater invest sales operating have a to growth both including so and the domestically. in revenue, reduce also organization other marketing, right drive measures preserve internationally drivers and future
are confident simple, that we're but therapies. it growth, leading improvements seems pleased to I'm rollout successful. Our to the to very takes completed our calibration our in It the new be second at made the good we strategy, team limited report, is be products pillar commercialize of products having experience this and release months. to going coming a I'm full for planning additional have it and disposable develop and and ReShape tubes, to
is and provides procedures future sleeve bariatric procedures, tubes defects and rapidly gastric the of this in We surgeons, to it adopted revenues. extension expect a be this to broad easier visualize a to given used gastrectomy than such making clear, the increase other product lap by calibration better as therefore potential anatomy, be band line of their To opportunity range bypass. great to ability identify laparoscopic help during
is on platform. management reshapecare impact a imperative the XXXX. discussing space, are virtual how care product delivery commercializing reshapecare, is loss $XX to we our touch billion by second entire weight and The market weight that that health the it's virtual we reach continuum, When will we expected
platform. area win by their telehealth counseling Reshapecare journey, the our loss treatment weight leveraging supports will patients pathway. in coaches We this throughout and regardless of
itself and pleased support a costs. and line recently patient received, health ReShape the that and are to Lap-Band loss program reduce we about stress. premium exercise, expanding program spoke leads recommended and of that this are to we both valuable platforms strategy. reception employee e-commerce an distinguish employers health its Both weight impact we with to reshapecare, extension large have includes care care are employers' provider address place, weight advanced as achieve key positive retention their employees Optimize ReShape our Reshapecare Based competitively feedback, wellness our how overall sleep patient Marketplace, products, on engagement ReShape health to supplements, self-insured allows to We potential incredibly improve with our with health important platform and and and partners' nutrition, can our this element loss. and help this
postoperative is potential of Lap-BandX. the while society. obstructions, adjustments goal patient was of redesign discomfort the reduce started horizon, and the with launch by On the minimizing maintaining physician-led to next-generation for project a This Lap-Band minimize
As this too to you are much surgeons as design incorporates excited The in past. the the part report, of who I've for tube from these future band designed previous about may reservoir the about We're those spoken this clearance engage relief XXXX, recall Lap-Band enhanced next-gen Lap-Band first tuned new valve, of that the us device. with alleviate to we noted are technology reengage discomfort a food. with in the an FDA. Lap-Band. Surgeons allow new serves from to that believe, for used Lap-Band tube the swallowing to excited submit commonly I'm drawbacks have will Stay and expected updates, updates.
diabetes the remains the which prescribed. treat the is in and As to the development an type estimated considered DBSN challenging take our XX have especially from published address device global two was two for suffer in recently significant block during effectively advanced do market. device, Neuroscience, over the also excitingly, as million presented of Americans neuromodulation, Type the of stem diabetes abstract on not we potential diabetes Frontiers medications to journal diabetics two who disease, ObesityWeek. an XX% in type Data was peer-reviewed our
vagus need and potential improved belief our resistance, hold system information which decrease by stimulating development nerve prescription vagus focus blocking by ability brain the release super diabetes insulin. been further that, unlocked device designed funding thus treatment has nerve significant the depression treat providing and This type SBIR We address and the SBIR unmet numerous and Research internal this is it's feeding technology Grant, tremendous we has concurrently Business as current the hypoglycemia. compelling that in failed to have promise, incredible the or insulin nerves our to for may on durability a as every may organs. diabetes. non-pharmacological electrically the human DBSN as been innovative address action The to to on DBSN NIH body. epilepsy. new has the in advantages two have subsequent while nearly believe far funded deliver grant Innovation manner physiological diseases the has this shown strong patient-specific addressing over in for diabetes support signals The nerve SBIR involved received serves type The to vagus shown pancreas, a to carrying generated Our grant to vagus efficacy validates X treatments clear Small data It treatments X the options. which and into of this highway, between was an such
role are and future continued collaborate about researchers very its seek with with continue we'll excited therapy, this personalized support. NIH fighting obesity non-dilutive and grant and We to leading in technology
for efficacy continuum. the ReShape I'm last and based pillar evidence. pleased to few provide third products supported clinical strong our evidence and care an need In are Lap-Band. gain by growth months we search that, tremendous for and have other say The words, is last to ensuring to therapies by been
and Society XX-year-old American for the the Metabolic Surgery of overdue, surgery children greater and even Specifically, or BMI by should the who selected Disorders for for The guidelines adolescence. and is people surgery recent Obesity Lap-Band, new International disease, metabolic These BMI bariatric were and patients which the co-morbidity, obesity-related loss for of be least patient Federation with long appropriate ReShape. bode achieved replacing weight for in ASMBS, & than a methods. the BMI or evidence-based whose IFSO improvement Surgery with updates any Metabolic non-surgical Bariatric guidelines guidelines weight of as absence guidelines or for issued not that individuals, the or conditions, durable for XXXX. by loss is over have metabolic as well XX recommend guidelines issued with over will considered of at states without the or with XX, a or and approved metabolic of more, a presence, an be adults NIH substantial The FDA XX. for XX align bariatric adult option regardless of a and further BMI surgery disease, an XX, The to BMI as by obesity-related one considered using XX.X, metabolic now and well with with well the severity conditions obesity-related that and
only is device Importantly, market. on laparoscopic weight the years XX Lap-Band loss the by of the FDA-approved clinical evidence backed
of surgery number supported personalized eligible and these the patients approved a new if it's guidelines least surgical increase invasive that prevail procedures, our as belief As among result, for dramatically will by strong can the bariatric Lap-Band, treatment payers the option.
many issued statement that management, and of in a anatomy in and guidelines safe In ASMBS solution. the to that validating We perfectly effective is use a new the weightless recommendations. pleased the consensus to ReShape's statement Lap-Band were reached IFSO, October issued with the evidence-based determinations sparing own aftercare on aligned best with conjunction practices Lap-Band addition the see in
we to the related I to it, aftercare experts statement critical aligns nationwide patients, concluded of coaching for key will is the and the also aftercare, the to we loss procedure. believe behavioral is is bariatric with effective the the health, and loss the statement that loss that and our weight Additionally, weight concluded procedure. critical That issued virtual nutrition related component who this health through success because for convenient success offer proper of important, also aftercare nutrition behavioral pre weight of consensus that again, say Lap-Band postsurgical including consensus which program patients. health reshapecare and all proper the
philosophy strategy, front partner benefits of the and care on professionals as are surgeons surgeons train to comprehensive such the ensuring our educated to critical and our a Our to core organizations ASMBS Lap-Band the with is health on is the piece fully identify of that, lines Program. and
safe, loss care the provide can required results. So, for durable that patients to achieve, we together, long-term
provide the for updated ReShape. driving top line adoption to crucial future and together, a statement consensus component Taken revenue the and guidelines
Now I highlight our additional not in that call over to metrics recap our financial to to captured are want the turn Tom before I XX-Q. some performance,
third focused primarily resources the resources and sales, our to As an international tough, predictable scalable and we this you profitability. highlight can business mission, and Tom made trend. decline This reversing to will adjustments growth. our the will have discussing our necessary all in the Operationally, due of that of part we to our to international but moved important and change, have lack shorten and confident now I'm right-size to quarter have lead on our effect When will path organization quickly to is we focus. appreciate, revenue, path
COVID's to For our has and It a been even has how months early individuals discussed, the US temporary. sales program six complex generation commit This surgery. over previously setback it real, in but lead sales, our impacted is bariatric up or how to variant also loss year may journey been for pre-supported, weight take it XXXX. was and Omicron to
both of for are Our success, indicators beginning are There partners commercialization the support team of growth In year. twice we to now surgeon our comprised are and surgeons by surgeons of clearly Lap-Band. to October, last Lap-Band to In than have trained October's XX% XX% sales XXXX, early have now we growth. offer engaged, marketing used the aligned we and more of number in Lap-Band. drive XXXX. October including the and some than offering evidenced alone, the had surgeons is more revenue compared number This
revenue I've stated, now our are to metrics, performance. Stankovich of provide the to the optimistic established a we As over to Tom we about turn we top like model Tom? business have and profitability. I'd optimize our line will recap financial to continue drive and call to
